A novel approach to evaluate the validity of thrombolytic treatment in acute myocardial infarction.
D000136:Acid-Base Equilibrium; D000208:Acute Disease; D001794:Blood Pressure; D001809:Blood Viscosity; D002302:Cardiac Output; D002395:Catecholamines / Q000652:urine; D002496:Central Venous Pressure; D003325:Coronary Care Units; D004452:Echocardiography; D004562:Electrocardiography; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005340:Fibrinogen / Q000378:metabolism; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006863:Hydrogen-Ion Concentration; D007734:Kymography; D007773:Lactates / Q000097:blood; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism; D011651:Pulmonary Artery; D011877:Radionuclide Imaging; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014655:Vascular Resistance
D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D005340:Fibrinogen; D013300:Streptokinase; D006854:Hydrocortisone